⌘K

Login Start Free

Home/Filings/4/0001213900-21-050751

4//SEC Filing

ADAMS ERIC A 4

Accession 0001213900-21-050751

CIK 0001728328other

View on SEC.gov Company Profile

Filed

Sep 29, 8:00 PM ET

Accepted

Sep 30, 1:39 PM ET

Size

4.5 KB

Accession

0001213900-21-050751

Insider Transaction Report

Form 4

Period: 2021-09-29

InMed Pharmaceuticals Inc.INM

DirectorCEO & President10% Owner

Transactions

Purchase
Common Stock
2021-09-29$1.73/sh+8,800$15,224→ 36,283 total

Documents

1 file

4
ownership.xmlPrimary

Issuer

InMed Pharmaceuticals Inc.

CIK 0001728328

Entity typeother

Related Parties

1

filerCIK 0001817882

Filing Metadata

Form type: 4
Filed: Sep 29, 8:00 PM ET
Accepted: Sep 30, 1:39 PM ET
Size: 4.5 KB

View on SEC.gov